HilleVax, Inc. 3 SEC Filings

Filed On	Filing
26 Jan 2024	Form 3: McLoughlin Sean, Chief Operating Officer No securities owned
10 May 2023	Form 3: Cocero Nanette, Director No securities owned
10 Jan 2023	Form 3: Maltbie Shane, Chief Financial Officer Holds 899 shares of Common Stock
29 Apr 2022	Form 3: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other Holds 500,000 shares of Common Stock
28 Apr 2022	Form 3: Kohli Aditya, Director Holds 736,278 shares of Common Stock
28 Apr 2022	Form 3: Hilleman Jeryl L, Director Holds 42,025 shares of Common Stock
28 Apr 2022	Form 3: Borkowski Astrid, Chief Medical Officer Holds 168,100 shares of Common Stock
28 Apr 2022	Form 3: Gerberding Julie L., Director Holds 42,025 shares of Common Stock
28 Apr 2022	Form 3: Dubin Gary, Director No securities owned
28 Apr 2022	Form 3: Sepulveda Jaime, Director Holds 42,025 shares of Common Stock
28 Apr 2022	Form 3: Frazier Life Sciences X, L.p., 10% owner and 4 others Holds 4,034,397 shares of Common Stock
28 Apr 2022	Form 3: Socks David A, CFO & Chief Business Officer Holds 769,055 shares of Common Stock
28 Apr 2022	Form 3: Chu Shelley, Director No securities owned
28 Apr 2022	Form 3: Hershberg Robert, Director Holds 777,462 shares of Common Stock
28 Apr 2022	Form 3: Silbermann Susan Michele, Director Holds 42,025 shares of Common Stock

Comments